Neurocrine Biosciences, Inc.

DB:NB3 Stock Report

Market Cap: €11.4b

Neurocrine Biosciences Future Growth

Future criteria checks 5/6

Neurocrine Biosciences is forecast to grow earnings and revenue by 30.4% and 14% per annum respectively. EPS is expected to grow by 28.6% per annum. Return on equity is forecast to be 26.1% in 3 years.

Key information

30.4%

Earnings growth rate

28.6%

EPS growth rate

Biotechs earnings growth36.0%
Revenue growth rate14.0%
Future return on equity26.1%
Analyst coverage

Good

Last updated02 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:NB3 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,2289209221,05218
12/31/20252,74464974482223
12/31/20242,35742760657021
9/30/20242,243386440476N/A
6/30/20242,120339495530N/A
3/31/20241,982370614645N/A
12/31/20231,887250362390N/A
9/30/20231,784191385409N/A
6/30/20231,673176281296N/A
3/31/20231,59964237255N/A
12/31/20221,489155323339N/A
9/30/20221,38958177201N/A
6/30/20221,29712133164N/A
3/31/20221,20871102129N/A
12/31/20211,13490233257N/A
9/30/20211,069445328347N/A
6/30/20211,032365251265N/A
3/31/20211,045402266280N/A
12/31/20201,046407218229N/A
9/30/20201,04293222232N/A
6/30/20201,006205337350N/A
3/31/2020887177283295N/A
12/31/201978837132147N/A
9/30/20196752182100N/A
6/30/2019605184471N/A
3/31/2019519-39027N/A
12/31/20184512177101N/A
9/30/2018414107091N/A
6/30/2018323-52N/A13N/A
3/31/2018233-106N/A-55N/A
12/31/2017162-143N/A-94N/A
9/30/201767-194N/A-167N/A
6/30/20176-220N/A-188N/A
3/31/2017N/A-200N/A-154N/A
12/31/201615-141N/A-106N/A
9/30/201615-126N/A-90N/A
6/30/201615-123N/A-77N/A
3/31/201615-107N/A-49N/A
12/31/201520-89N/A-38N/A
9/30/201520-79N/A-38N/A
6/30/201520-60N/A-32N/A
3/31/201520-50N/A-56N/A
12/31/2014N/A-61N/A-47N/A
9/30/20141-52N/A-43N/A
6/30/20141-47N/A-41N/A
3/31/20142-46N/A-41N/A
12/31/20133-46N/A-30N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NB3's forecast earnings growth (30.4% per year) is above the savings rate (0.8%).

Earnings vs Market: NB3's earnings (30.4% per year) are forecast to grow faster than the German market (20.1% per year).

High Growth Earnings: NB3's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: NB3's revenue (14% per year) is forecast to grow faster than the German market (5.5% per year).

High Growth Revenue: NB3's revenue (14% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: NB3's Return on Equity is forecast to be high in 3 years time (26.1%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y